Jenoptik

30/09/26 -"As we expect higher overall profitability, we have slightly increased our EV/EBITDA multiples used for valuing specific divisions. Biophotonics, which includes the defence business, has been raised ..."

PDF page sample
Pages
51
Language
English
Published on
30/09/26
Download
You may also be interested by these reports :
30/09/26
Should one chase the 5.7% yield that Real Estate dangles? Or forget yield altogether, buy Semiconductors and pray? Below is the pecking order of ...
30/09/26
As we expect higher overall profitability, we have slightly increased our EV/EBITDA multiples used for valuing specific divisions. Biophotonics, ...
18/09/26
STMicroelectronics (BUY, Netherlands) equity story has transformed from one of Automotive semiconductors and Industrial Microcontrollers to one of a ...
12/08/26
Jenoptik delivered a strong H1 26. Semiconductors and advanced manufacturing remained the key growth engines, while biophotonics benefited from ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO